SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,151.04 905.01
( 1.24%)

Global Indices

Nasdaq

52,520.99 122.42
(0.23%)

Dow Jones

7,766.26 22.66
(0.29%)

Hang Seng

64,627.45 673.26
(1.05%)

Nikkei 225

10,683.77 -2.77
(-0.03%)

Forex

USD-INR

95.08 -0.03
(-0.03%)

EUR-INR

106.01 -0.48
(-0.45%)

GBP-INR

126.67 -0.36
(-0.28%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jenburkt Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524731

INE354A01013

446.4690821

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JENBURPH

10.82

386.58

EPS(TTM)

Face Value()

Div & Yield %

80.96

2.36

Back

alembic ltd

Regent Enterprises standalone net profit rises 54.27% in the June 2026 quarter

Aug 13,2026

Net profit of Regent Enterprises rose 54.27% to Rs 2.53 crore in the quarter ended June 2026 as against Rs 1.64 crore during the previous quarter ended June 2025. Sales declined 42.07% to Rs 138.27 crore in the quarter ended June 2026 as against Rs 238.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	138.27	238.67	-42
OPM %	1.27	0.74	-
PBDT	1.76	1.77	-1
PBT	1.63	1.64	-1
NP	2.53	1.64	54

74,151.04 905.01 ( 1.24%)

52,520.99 122.42 (0.23%)

7,766.26 22.66 (0.29%)

64,627.45 673.26 (1.05%)

10,683.77 -2.77 (-0.03%)

95.08 -0.03 (-0.03%)

106.01 -0.48 (-0.45%)

126.67 -0.36 (-0.28%)

0.60 0.00 (-0.36%)